Evidence map›Paper›PMID 25780059›Full record

ReviewTherapeutic advances in cardiovascular disease2015

Roles of collecting duct renin and (pro)renin receptor in hypertension: mini review.

Alexis A Gonzalez, Minolfa C Prieto

Open access · bronzeAbstract readReview
In one paragraph

Review in Therapeutic advances in cardiovascular disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Oxidative Stress in Kidney Injury and Hypertension.Antioxidants (Basel, Switzerland) · 2024
    Review
  2. Article
  3. Flexible and multifaceted: the plasticity of renin-expressing cells.Pflugers Archiv : European journal of physiology · 2022
    Review
  4. Article
  5. Patterns of differentiation of renin lineage cells during nephrogenesis.American journal of physiology. Renal physiology · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. (Pro)renin receptor regulates lung development via the Wnt/β-catenin signaling pathway.American journal of physiology. Lung cellular and molecular physiology · 2019
    Article
  10. Article
  11. Review
  12. Review
  13. Bradykinin/BPhysiological reports · 2017
    Article
  14. Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?American journal of physiology. Heart and circulatory physiology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Alexis A GonzalezInstituto de Química, Pontificia Universidad Católica de Valparaíso, Chile.
Minolfa C PrietoDepartment of Physiology, Rm 4061, Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112, USA mprieto@tulane.edu.
Pontificia Universidad Católica de Valparaíso · CLTulane University · US

Funding

TULANE COBRE: TRANSGENIC &GENE-TARGETED ANIMAL COREP20RR017659 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI PRIETO, MINOLFA C · 2002 to 2011
$22.1M
Translational Research in Hypertension and Renal BiologyP30GM103337 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI NAVAR, LUIS GABRIEL · 2012 to 2016
$5.8M
PLEIOTROPIC EFFECTS OF PRORENIN RECEPOR IN COLLECTING DUCT AND INTRARENAL RAS ACTIVATIONR01DK104375 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI PRIETO, MINOLFA C · 2014 to 2018
$1.7M
NCRR NIH HHS P20 RR017659NCRR NIH HHS P20RR-017659NIDDK NIH HHS DK104375-01NIDDK NIH HHS R01 DK104375NIGMS NIH HHS P30 GM103337
6 · The paper itself

Abstract

In angiotensin (Ang)-II-dependent hypertension, collecting duct renin synthesis and secretion are stimulated despite suppression of juxtaglomerular (JG) renin. This effect is mediated by Ang II type 1 (AT1) receptor independent of blood pressure. Although the regulation of JG renin is known, the mechanisms by which renin is regulated in the collecting duct are not completely understood. The presence of renin activity in the collecting duct may provide a pathway for intratubular Ang II formation since angiotensinogen substrate and angiotensin converting enzyme are present in the distal nephron. The recently named new member of the renin-angiotensin system (RAS), the (pro)renin receptor [(P)RR], is able to bind renin and the inactive prorenin, thus enhancing renin activity and fully activating prorenin. We have demonstrated that renin and (P)RR are augmented in renal tissues from rats infused with Ang II and during sodium depletion, suggesting a physiological role in intrarenal RAS activation. Importantly, (P)RR activation also causes activation of intracellular pathways associated with increased cyclooxygenase 2 expression and induction of profibrotic genes. In addition, renin and (P)RR are upregulated by Ang II in collecting duct cells. Although the mechanisms involved in their regulation are still under study, they seem to be dependent on the intrarenal RAS activation. The complexities of the mechanisms of stimulation also depend on cyclooxygenase 2 and sodium depletion. Our data suggest that renin and (P)RR can interact to increase intratubular Ang II formation and the activation of profibrotic genes in renal collecting duct cells. Both pathways may have a critical role in the development of hypertension and renal disease.

Indexed as

Angiotensin IIAngiotensinogenAnimalsBlood PressureHumansHypertensionKidney DiseasesPeptidyl-Dipeptidase AProrenin ReceptorRatsReceptors, Cell SurfaceReninRenin-Angiotensin SystemVacuolar Proton-Translocating ATPasesAngiotensin IIAngiotensinogenATP6AP2 protein, humanPeptidyl-Dipeptidase AProrenin ReceptorReceptors, Cell SurfaceReninVacuolar Proton-Translocating ATPasesangiotensin II dependent hypertensionrenin angiotensin systemsignaling pathways

Identifiers

PMID25780059
PMCPMC4560657
OpenAlexW2086070417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.